At this point  RVX need something huge to shock the market, like a BP investment/partnership,   for the trials  to move forward and  for the SP to get back to a respectable level.  I am surprised that the Insiders, Eversana, Oristar /Hepa. Dart  etc are staying the course. I suppose they know somthing we don't know , a sale at the $1  USdBillion level isn't going to happen at this level, I suppose rumours would creep it up and maybe boom... I just don't see it until BP makes shows more of an interest, What is that catalyst. It defintely not artices in  publications validating Apabetalone to move forward in trials. maybe the FDA can bridge the gap.......